Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita.
Hsp70
autoantibodies
autoimmune bullous diseases (AIBDs)
epidermolysis bullosa acquisita (EBA)
heat shock proteins (Hsps)
interferon gamma (IFN-γ)
nuclear factor kappa B (NF-κB)
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
02
2022
accepted:
28
03
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
Stress-induced heat shock protein 70 (Hsp70) is a key intra- and extracellular molecular chaperone implicated in autoimmune processes. Highly immunogenic extracellular Hsp70 can activate innate and acquired (adaptive) immune responses driving the generation of anti-Hsp70 autoantibodies that are frequently observed in inflammatory/autoimmune disorders. We recently described the direct pathological role of extracellular Hsp70 in epidermolysis bullosa acquisita (EBA), an anti-type VII collagen autoantibody-mediated autoimmune blistering skin disease. Here, we determined the role of anti-Hsp70 autoantibodies in EBA. We observed that circulating anti-Hsp70 IgG autoantibodies were significantly elevated in EBA patients compared to healthy individuals and positively correlated with serum levels of pro-inflammatory interferon gamma (IFN-γ). The pathophysiological relevance of anti-Hsp70 IgG autoantibodies was demonstrated in an antibody transfer-induced EBA mouse model in which elevated serum levels of anti-Hsp70 IgG were found. In addition, anti-Hsp70 IgG-treated animals had a more intense clinical and histological disease activity, as well as upregulated nuclear factor kappa B (NF-κB) activation in skin biopsies compared to isotype-treated animals. Our results suggest that autoantibodies to Hsp70 may contribute to EBA development
Identifiants
pubmed: 35514963
doi: 10.3389/fimmu.2022.877958
pmc: PMC9065281
doi:
Substances chimiques
Autoantibodies
0
HSP70 Heat-Shock Proteins
0
Immunoglobulin G
0
NF-kappa B
0
anti-type VII collagen autoantibody
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
877958Informations de copyright
Copyright © 2022 Tukaj, Mantej, Sitko, Zillikens, Ludwig, Bieber and Kasperkiewicz.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Invest Dermatol. 2017 Feb;137(2):341-349
pubmed: 27659253
J Steroid Biochem Mol Biol. 2017 Oct;173:23-27
pubmed: 27760369
FEBS Lett. 2011 Jun 23;585(12):1748-52
pubmed: 21570975
Int J Mol Sci. 2020 Jul 26;21(15):
pubmed: 32722570
Cell Stress Chaperones. 2019 Jan;24(1):283-287
pubmed: 30465159
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14134-9
pubmed: 22891339
J Immunol. 2015 Sep 1;195(5):1945-54
pubmed: 26202985
J Invest Dermatol. 2018 Feb;138(2):301-309
pubmed: 28942362
J Immunol. 2010 Feb 1;184(3):1596-603
pubmed: 20038644
Exp Dermatol. 2022 Apr;31(4):528-534
pubmed: 34741567
J Inflamm (Lond). 2014 Apr 02;11(1):10
pubmed: 24694060
Cell Stress Chaperones. 2014 Nov;19(6):837-43
pubmed: 24643797
J Immunol. 2011 Nov 15;187(10):5043-50
pubmed: 21967893
J Invest Dermatol. 2016 Jan;136(1):24-33
pubmed: 26763420
Cell Stress Chaperones. 2014 Nov;19(6):887-94
pubmed: 24796797
Front Immunol. 2021 Feb 23;12:614320
pubmed: 33708208
Front Immunol. 2021 Aug 09;12:716469
pubmed: 34434197
Cell Stress Chaperones. 2019 May;24(3):475-479
pubmed: 31073900
Exp Dermatol. 2017 Dec;26(12):1175-1178
pubmed: 28857285